CytomX Therapeutics Inc (FRA:6C1)
€ 2.829 -0.042 (-1.46%) Market Cap: 647.67 Mil Enterprise Value: 345.02 Mil PE Ratio: 0 PB Ratio: 2.23 GF Score: 36/100

CytomX Therapeutics Inc (FRA:6C1) Transcripts

  • 1